Cargando…
Low-Dose Aspirin Therapy in Patients With Type 2 Diabetes and Reduced Glomerular Filtration Rate: Subanalysis from the JPAD trial
OBJECTIVE: Type 2 diabetes accompanied by renal damage is a strong risk factor for atherosclerotic events. The purpose of this study was to investigate the efficacy of low-dose aspirin therapy on primary prevention of atherosclerotic events in patients with type 2 diabetes and coexisting renal dysfu...
Autores principales: | Saito, Yoshihiko, Morimoto, Takeshi, Ogawa, Hisao, Nakayama, Masafumi, Uemura, Shiro, Doi, Naofumi, Jinnouchi, Hideaki, Waki, Masako, Soejima, Hirofumi, Sugiyama, Seigo, Okada, Sadanori, Akai, Yasuhiro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024334/ https://www.ncbi.nlm.nih.gov/pubmed/21270185 http://dx.doi.org/10.2337/dc10-1615 |
Ejemplares similares
-
Differential Effect of Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Diabetes Management: A subanalysis of the JPAD trial
por: Okada, Sadanori, et al.
Publicado: (2011) -
Is Long-Term Low-Dose Aspirin Therapy Associated with Renal Dysfunction in Patients with Type 2 Diabetes? JPAD2 Cohort Study
por: Okada, Sadanori, et al.
Publicado: (2016) -
Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus
por: Matsumoto, Chisa, et al.
Publicado: (2022) -
Initial Acute Decline in Estimated Glomerular Filtration Rate After Sodium-Glucose Cotransporter-2 Inhibitor in Patients With Chronic Kidney Disease
por: Sugiyama, Seigo, et al.
Publicado: (2020) -
Total adiponectin is associated with incident cardiovascular and renal events in treated hypertensive patients: subanalysis of the ATTEMPT-CVD randomized trial
por: Kim-Mitsuyama, Shokei, et al.
Publicado: (2019)